ValiRx plc (LON:VAL – Get Free Report) shot up 29.2% during trading on Tuesday. The stock traded as high as GBX 0.19 and last traded at GBX 0.17. 105,847,453 shares traded hands during trading, an increase of 921% from the average session volume of 10,371,050 shares. The stock had previously closed at GBX 0.13.
ValiRx Stock Performance
The stock’s 50-day simple moving average is GBX 0.14 and its 200 day simple moving average is GBX 0.18. The company has a market capitalization of £1.77 million, a PE ratio of -0.33 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last released its quarterly earnings data on Tuesday, September 15th. The company reported GBX (0.09) earnings per share (EPS) for the quarter. ValiRx had a negative return on equity of 71.49% and a negative net margin of 6,548.06%. On average, analysts expect that ValiRx plc will post -1.74 earnings per share for the current year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Are RTX Corporation and Northrop Grumman Ready to Break Out?
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
